These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6439360)

  • 1. Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction.
    Evans WV
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1649-51. PubMed ID: 6439360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction.
    Miller AJ; Boroda C; Levy J
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):159-60. PubMed ID: 3917731
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eaton ML; MacDonald FM; Church TR; Niewoehner DE
    Chest; 1982 Nov; 82(5):538-42. PubMed ID: 7128220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
    McKay SE; Howie CA; Thomson AH; Whiting B; Addis GJ
    Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
    Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
    Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release theophylline in chronic bronchitis.
    Anderson G; Peel ET; Pardoe T; Jones R
    Br J Dis Chest; 1982 Jul; 76(3):261-5. PubMed ID: 6751366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
    Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA
    Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo.
    Van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):638-42. PubMed ID: 3025113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
    Murciano D; Auclair MH; Pariente R; Aubier M
    N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of theophylline in "irreversible" airflow obstruction.
    Eaton ML; Green BA; Church TR; McGowan T; Niewoehner DE
    Ann Intern Med; 1980 Jun; 92(6):758-61. PubMed ID: 7387018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinflation, trapped gas and theophylline in chronic obstructive pulmonary disease.
    Waterhouse JC; Pritchard SM; Howard P
    Monaldi Arch Chest Dis; 1993; 48(2):126-9. PubMed ID: 8518774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow release theophyllines and chronic bronchitis.
    Cochrane GM
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1643-4. PubMed ID: 6439357
    [No Abstract]   [Full Text] [Related]  

  • 17. Theophylline in stable chronic airflow obstruction. A reappraisal.
    Dull WL; Alexander MR
    Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction.
    Addis GJ
    Br Med J (Clin Res Ed); 1985 Feb; 290(6466):466-7. PubMed ID: 3918633
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking.
    Jenne JW; Siever JR; Druz WS; Solano JV; Cohen SM; Sharp JT
    Am Rev Respir Dis; 1984 Oct; 130(4):600-5. PubMed ID: 6486559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome.
    Eiser N; Denman WT; West C; Luce P
    Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.